TMA Executive Director celebrated

At the recent annual meeting of the International Myositis Assessment and Clinical Studies Group (IMACS) in Chicago, more than 130 international myositis experts joined in recognizing TMA’s retiring Executive Director Bob Goldberg.

Continue Reading
Mother and Daughter Hugging

Lenabasum questions answered

Excitement is building for Corbus Pharmaceutical’s Phase 3 clinical trial testing the safety and effectiveness of their new drug lenabasum in dermatomyositis patients.

Continue Reading
Doctor Working on Computer

Research grants awarded

The Myositis Association announces the awarding of three new research grants to fund basic and applied investigations in myositis diseases.

Continue Reading